Valuation ratios measure the quantity of an asset or flaw (e.g., earnings) associated with ownership of a specified claim (e.g., a share of ownership of the enterprise).
Historical Valuation Ratios (Summary)
Based on: 10-Q (reporting date: 2024-06-30), 10-K (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-K (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30).
The analysis of the financial ratios over the reported periods reveals several noteworthy trends and fluctuations that provide insight into the company's valuation metrics and market perception.
- Price to Earnings (P/E) Ratio
- The P/E ratio shows a substantial increase beginning in the second quarter of 2020, surging from 46.33 to a peak of 236.37 in the second quarter of 2021. Following this peak, there is a marked decline through 2021 into early 2022, reaching 59.14 by the first quarter of 2022. Subsequently, the ratio demonstrates some volatility but generally trends upward again, fluctuating between 44.49 and 91.18 in the latest periods. This pattern suggests initial market optimism or anticipated earnings growth during 2020 and 2021, followed by a correction and stabilized but still elevated valuation levels.
- Price to Operating Profit (P/OP) Ratio
- Similar to the P/E ratio, the P/OP ratio shows a sharp rise starting in mid-2020, climbing from 27.67 to a high of 156.71 by mid-2021. Thereafter, it declines steadily to a low of 40.94 by late 2023 before rebounding moderately to around 64.89 by mid-2024. The observed pattern parallels the P/E ratio's behavior, indicating that market pricing relative to operating profits was elevated in 2020-2021, followed by a correction phase and partial recovery.
- Price to Sales (P/S) Ratio
- This ratio indicates a steady upward trajectory from 2.93 in mid-2019 to a peak of 10.78 in early 2023. After this peak, it experiences some decline but remains significantly higher than earlier periods, settling near 8.01 by mid-2024. The trend reflects increasing market valuations relative to sales, which might suggest either revenue growth expectations or premium valuation multiples assigned by investors.
- Price to Book Value (P/BV) Ratio
- The P/BV ratio exhibits consistent growth over the entire span, rising from 3.89 in mid-2019 to a notable high of 16.09 by late 2023. This indicates a sustained increase in market valuation relative to the company's net book value, peaking around the same time as other valuation multiples. The subsequent decline to 12.89 by mid-2024 remains indicative of strong investor confidence compared to earlier periods.
Overall, the data reveal significant appreciation in valuation metrics starting mid-2020, peaking mainly during 2021 to early 2023, followed by phases of correction and stabilization. The rise in price-based ratios relative to earnings, operating profit, sales, and book value suggests elevated market expectations and substantial growth anticipation. Fluctuations after the peaks may reflect changing market conditions, adjustments in earnings outlook, or broader economic factors affecting investor sentiment.
Price to Earnings (P/E)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. shares of common stock outstanding1 | 56,388,228 | 55,939,080 | 55,506,934 | 55,199,220 | 54,457,319 | 53,867,072 | 53,294,702 | 52,938,112 | 52,424,445 | 52,272,764 | 52,120,683 | 52,031,436 | 51,826,156 | 51,649,915 | 51,240,997 | 51,033,310 | 50,721,893 | 50,009,051 | 49,958,125 | 49,999,358 | 49,867,321 | |||||||
Selected Financial Data (US$) | ||||||||||||||||||||||||||||
Net income (in thousands) | 47,555) | 14,527) | 26,888) | 33,271) | 52,977) | 16,246) | 19,105) | 11,710) | 14,469) | 1,556) | 6,214) | 5,724) | 8,276) | (24) | 4,297) | 447) | 1,512) | (341) | 8,002) | 6,517) | 3,706) | |||||||
Earnings per share (EPS)2 | 2.17 | 2.28 | 2.33 | 2.20 | 1.84 | 1.14 | 0.88 | 0.64 | 0.53 | 0.42 | 0.39 | 0.35 | 0.25 | 0.12 | 0.12 | 0.19 | 0.31 | 0.36 | 0.00 | 0.00 | 0.00 | |||||||
Share price1, 3 | 160.83 | 184.77 | 164.82 | 98.01 | 133.19 | 104.15 | 67.29 | 48.09 | 36.18 | 24.63 | 28.52 | 30.21 | 29.83 | 28.52 | 23.12 | 19.43 | 20.54 | 16.57 | 18.93 | 17.29 | 17.31 | |||||||
Valuation Ratio | ||||||||||||||||||||||||||||
P/E ratio4 | 74.19 | 80.96 | 70.71 | 44.49 | 72.50 | 91.18 | 76.56 | 74.99 | 67.83 | 59.14 | 73.62 | 86.02 | 118.96 | 236.37 | 200.29 | 103.07 | 66.40 | 46.33 | — | — | — | |||||||
Benchmarks | ||||||||||||||||||||||||||||
P/E Ratio, Competitors5 | ||||||||||||||||||||||||||||
Procter & Gamble Co. | 28.75 | 27.11 | 25.14 | 25.01 | 23.65 | 25.47 | 26.20 | 24.00 | 21.49 | 23.91 | 27.43 | 27.29 | 24.55 | 24.46 | 24.20 | 23.92 | 26.27 | 25.85 | 63.19 | 67.79 | 75.63 |
Based on: 10-Q (reporting date: 2024-06-30), 10-K (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-K (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 Q1 2025 Calculation
EPS
= (Net incomeQ1 2025
+ Net incomeQ4 2024
+ Net incomeQ3 2024
+ Net incomeQ2 2024)
÷ No. shares of common stock outstanding
= (47,555,000 + 14,527,000 + 26,888,000 + 33,271,000)
÷ 56,388,228 = 2.17
3 Closing price as at the filing date of e.l.f. Beauty, Inc. Quarterly or Annual Report.
4 Q1 2025 Calculation
P/E ratio = Share price ÷ EPS
= 160.83 ÷ 2.17 = 74.19
5 Click competitor name to see calculations.
The share price of the company demonstrates an overall upward trend from June 30, 2019, to June 30, 2024, with fluctuations in certain quarters. The initial price of $17.31 rose to a peak of $67.29 by December 31, 2022, followed by a notable acceleration in growth reaching $184.77 by September 30, 2023. Subsequently, the share price experienced some volatility, declining to $160.83 by June 30, 2024. This pattern indicates increased market confidence and valuation in the latter years, despite short-term corrections.
Earnings per share (EPS) data, available from March 31, 2020, onward, shows consistent growth. Starting at $0.36 in March 2020, EPS displayed steady increases each quarter, reaching $2.28 by March 31, 2024, and slightly decreasing to $2.17 by June 30, 2024. This indicates improving company profitability over time, reflecting positively on operational performance and earnings quality.
The price-to-earnings (P/E) ratio exhibits volatility with elevated values throughout the observed period. Beginning at 46.33 in March 2020, the ratio surged above 200 in March 2021 and then declined moderately, fluctuating between approximately 44 and 91 in subsequent quarters. High P/E values suggest market expectations of growth, though the elevated and variable ratios also imply potential market uncertainty or high valuation relative to earnings growth.
- Share Price Trend
- Significant growth from approximately $17 to above $160 over five years with periods of rapid increase and intermittent declines, indicating strong share valuation development with some short-term volatility.
- Earnings Per Share (EPS)
- Consistent increase in earnings per share from $0.36 in early 2020 to a peak of around $2.28 in early 2024, signaling steady improvement in company profitability.
- Price-to-Earnings (P/E) Ratio
- High and variable P/E ratio suggesting optimistic investor expectations balanced by fluctuations that may reflect changing market sentiment or valuation pressure.
In summary, the financial indicators suggest robust growth in market valuation and profitability over the analyzed periods despite some fluctuations. The rising EPS supports the share price appreciation trend, while the elevated P/E ratios indicate the market prices in continued growth and possibly a premium valuation for the company's earnings performance.
Price to Operating Profit (P/OP)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. shares of common stock outstanding1 | 56,388,228 | 55,939,080 | 55,506,934 | 55,199,220 | 54,457,319 | 53,867,072 | 53,294,702 | 52,938,112 | 52,424,445 | 52,272,764 | 52,120,683 | 52,031,436 | 51,826,156 | 51,649,915 | 51,240,997 | 51,033,310 | 50,721,893 | 50,009,051 | 49,958,125 | 49,999,358 | 49,867,321 | |||||||
Selected Financial Data (US$) | ||||||||||||||||||||||||||||
Operating income (in thousands) | 50,708) | 17,030) | 31,836) | 40,179) | 60,633) | 8,045) | 23,291) | 15,377) | 21,430) | 2,186) | 8,971) | 7,442) | 11,171) | (1,868) | 6,291) | 1,968) | 3,009) | 1,040) | 12,880) | 9,102) | 6,928) | |||||||
Operating profit per share2 | 2.48 | 2.68 | 2.53 | 2.39 | 1.97 | 1.27 | 1.17 | 0.91 | 0.76 | 0.57 | 0.49 | 0.44 | 0.34 | 0.18 | 0.24 | 0.37 | 0.51 | 0.60 | 0.00 | 0.00 | 0.00 | |||||||
Share price1, 3 | 160.83 | 184.77 | 164.82 | 98.01 | 133.19 | 104.15 | 67.29 | 48.09 | 36.18 | 24.63 | 28.52 | 30.21 | 29.83 | 28.52 | 23.12 | 19.43 | 20.54 | 16.57 | 18.93 | 17.29 | 17.31 | |||||||
Valuation Ratio | ||||||||||||||||||||||||||||
P/OP ratio4 | 64.89 | 69.05 | 65.03 | 40.94 | 67.57 | 82.33 | 57.58 | 53.08 | 47.38 | 43.25 | 57.80 | 68.24 | 88.03 | 156.71 | 96.25 | 52.47 | 40.02 | 27.67 | — | — | — | |||||||
Benchmarks | ||||||||||||||||||||||||||||
P/OP Ratio, Competitors5 | ||||||||||||||||||||||||||||
Procter & Gamble Co. | 21.72 | 21.33 | 19.83 | 19.47 | 18.65 | 20.19 | 20.94 | 19.37 | 17.32 | 19.41 | 22.11 | 22.17 | 19.20 | 19.08 | 18.81 | 18.46 | 21.16 | 21.01 | 42.45 | 45.33 | 48.96 |
Based on: 10-Q (reporting date: 2024-06-30), 10-K (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-K (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 Q1 2025 Calculation
Operating profit per share
= (Operating incomeQ1 2025
+ Operating incomeQ4 2024
+ Operating incomeQ3 2024
+ Operating incomeQ2 2024)
÷ No. shares of common stock outstanding
= (50,708,000 + 17,030,000 + 31,836,000 + 40,179,000)
÷ 56,388,228 = 2.48
3 Closing price as at the filing date of e.l.f. Beauty, Inc. Quarterly or Annual Report.
4 Q1 2025 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 160.83 ÷ 2.48 = 64.89
5 Click competitor name to see calculations.
The financial data indicates several notable trends in the share price, operating profit per share, and their valuation ratio over the examined periods.
- Share Price
-
The share price demonstrated moderate fluctuations between June 2019 and early 2021, ranging roughly between $16 and $30. During this time, there was a general upward trend, with occasional declines such as the dip in March 2020. Starting mid-2021, the share price showed a substantial increase, rising from approximately $24.63 in March 2022 to a peak of $184.77 in September 2023. After this peak, the price decreased somewhat but remained elevated relative to earlier periods, ending at $160.83 in June 2024. This suggests a strong investor confidence and appreciation in the company's market valuation over the recent years.
- Operating Profit Per Share
-
Operating profit per share was not reported until March 2020, initiating at $0.60. From this point onward, the metric showed a consistent upward trend, indicating improving operating profitability on a per-share basis. There was a gradual increase from $0.18 in June 2021 to $2.68 in December 2023. A slight decline was seen in March and June 2024, but values remained above $2.4, signaling sustained profitability growth over the period analyzed.
- Price to Operating Profit (P/OP) Ratio
-
The P/OP ratio initially was fairly high and volatile, with values starting around 27.67 in March 2020 and escalating to over 150 in June 2021, illustrating a period of premium valuation relative to operating profits. Subsequently, the ratio decreased substantially to around 40-70 in the following years, reflecting either a correction in share price valuation or improved operating profits. The P/OP ratio’s downward trend post-2021 suggests that growth in operating profits may have outpaced increases in share price to some degree, indicating a more balanced valuation relative to operating earnings.
Overall, the data reveals significant growth in both share price and operating profitability per share since early 2020, with the valuation multiple exhibiting notable volatility but trending toward moderation in recent periods. This pattern may reflect a maturation phase where the company’s increasing profitability is being recognized more consistently by the market.
Price to Sales (P/S)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. shares of common stock outstanding1 | 56,388,228 | 55,939,080 | 55,506,934 | 55,199,220 | 54,457,319 | 53,867,072 | 53,294,702 | 52,938,112 | 52,424,445 | 52,272,764 | 52,120,683 | 52,031,436 | 51,826,156 | 51,649,915 | 51,240,997 | 51,033,310 | 50,721,893 | 50,009,051 | 49,958,125 | 49,999,358 | 49,867,321 | |||||||
Selected Financial Data (US$) | ||||||||||||||||||||||||||||
Net sales (in thousands) | 324,477) | 321,143) | 270,943) | 215,507) | 216,339) | 187,357) | 146,537) | 122,349) | 122,601) | 105,135) | 98,118) | 91,855) | 97,047) | 92,671) | 88,562) | 72,350) | 64,527) | 74,712) | 80,760) | 67,615) | 59,764) | |||||||
Sales per share2 | 20.08 | 18.30 | 16.04 | 13.87 | 12.35 | 10.75 | 9.32 | 8.47 | 7.97 | 7.50 | 7.28 | 7.11 | 6.77 | 6.16 | 5.86 | 5.73 | 5.67 | 5.66 | 0.00 | 0.00 | 0.00 | |||||||
Share price1, 3 | 160.83 | 184.77 | 164.82 | 98.01 | 133.19 | 104.15 | 67.29 | 48.09 | 36.18 | 24.63 | 28.52 | 30.21 | 29.83 | 28.52 | 23.12 | 19.43 | 20.54 | 16.57 | 18.93 | 17.29 | 17.31 | |||||||
Valuation Ratio | ||||||||||||||||||||||||||||
P/S ratio4 | 8.01 | 10.09 | 10.28 | 7.07 | 10.78 | 9.69 | 7.22 | 5.68 | 4.54 | 3.28 | 3.91 | 4.25 | 4.41 | 4.63 | 3.95 | 3.39 | 3.62 | 2.93 | — | — | — | |||||||
Benchmarks | ||||||||||||||||||||||||||||
P/S Ratio, Competitors5 | ||||||||||||||||||||||||||||
Procter & Gamble Co. | 4.81 | 4.71 | 4.44 | 4.32 | 4.25 | 4.46 | 4.54 | 4.19 | 3.82 | 4.31 | 4.93 | 4.96 | 4.41 | 4.51 | 4.50 | 4.39 | 4.88 | 4.65 | 4.24 | 4.44 | 4.43 |
Based on: 10-Q (reporting date: 2024-06-30), 10-K (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-K (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 Q1 2025 Calculation
Sales per share
= (Net salesQ1 2025
+ Net salesQ4 2024
+ Net salesQ3 2024
+ Net salesQ2 2024)
÷ No. shares of common stock outstanding
= (324,477,000 + 321,143,000 + 270,943,000 + 215,507,000)
÷ 56,388,228 = 20.08
3 Closing price as at the filing date of e.l.f. Beauty, Inc. Quarterly or Annual Report.
4 Q1 2025 Calculation
P/S ratio = Share price ÷ Sales per share
= 160.83 ÷ 20.08 = 8.01
5 Click competitor name to see calculations.
The analyzed financial data reveals several important trends over the periods from mid-2019 through mid-2024.
- Share Price
-
The share price shows a general upward trend with some notable fluctuations. Starting at approximately $17.31 in June 2019, the price experienced moderate increases and minor dips through early 2021, reaching around $28.52 in March 2021. Subsequently, the price exhibited strong growth, peaking at $184.77 in September 2023. However, after this peak, the price declined to about $160.83 by June 2024, indicating some volatility at elevated price levels. This overall increase suggests a significant appreciation in market valuation over the observed period.
- Sales Per Share
-
Sales per share data, available from the second quarter of 2020, illustrates consistent growth quarter over quarter. The figure rose from approximately $5.66 in June 2020 to $20.08 by June 2024. This steady increase demonstrates ongoing revenue growth on a per-share basis, indicating that the company's operational performance and sales efficiency improved substantially during the period.
- Price-to-Sales (P/S) Ratio
-
The P/S ratio initially showed some variation, starting around 2.93 in June 2020, increasing to above 4.5 by mid-2022, and peaking at approximately 10.78 in March 2023. The ratio then experienced a decline, settling near 8.01 by June 2024. This pattern reflects changing market valuations relative to sales, with the higher P/S ratios during 2022-2023 indicating optimism or higher growth expectations from the market. The subsequent decline suggests a partial correction or recalibration of investor expectations despite ongoing sales growth.
Overall, the financial indicators highlight a period of significant market value appreciation accompanied by consistent growth in sales on a per-share basis. The fluctuations in the P/S ratio underscore changing investor sentiment, with premium valuations during peak periods followed by some moderation. These trends collectively suggest improving business performance alongside evolving market perceptions of the company's future prospects.
Price to Book Value (P/BV)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. shares of common stock outstanding1 | 56,388,228 | 55,939,080 | 55,506,934 | 55,199,220 | 54,457,319 | 53,867,072 | 53,294,702 | 52,938,112 | 52,424,445 | 52,272,764 | 52,120,683 | 52,031,436 | 51,826,156 | 51,649,915 | 51,240,997 | 51,033,310 | 50,721,893 | 50,009,051 | 49,958,125 | 49,999,358 | 49,867,321 | |||||||
Selected Financial Data (US$) | ||||||||||||||||||||||||||||
Stockholders’ equity (in thousands) | 703,590) | 642,572) | 614,224) | 516,428) | 471,702) | 411,017) | 385,304) | 356,960) | 333,449) | 312,429) | 305,468) | 294,093) | 282,622) | 269,646) | 264,602) | 254,653) | 248,708) | 242,171) | 242,447) | 231,688) | 222,008) | |||||||
Book value per share (BVPS)2 | 12.48 | 11.49 | 11.07 | 9.36 | 8.66 | 7.63 | 7.23 | 6.74 | 6.36 | 5.98 | 5.86 | 5.65 | 5.45 | 5.22 | 5.16 | 4.99 | 4.90 | 4.84 | 4.85 | 4.63 | 4.45 | |||||||
Share price1, 3 | 160.83 | 184.77 | 164.82 | 98.01 | 133.19 | 104.15 | 67.29 | 48.09 | 36.18 | 24.63 | 28.52 | 30.21 | 29.83 | 28.52 | 23.12 | 19.43 | 20.54 | 16.57 | 18.93 | 17.29 | 17.31 | |||||||
Valuation Ratio | ||||||||||||||||||||||||||||
P/BV ratio4 | 12.89 | 16.09 | 14.89 | 10.48 | 15.38 | 13.65 | 9.31 | 7.13 | 5.69 | 4.12 | 4.87 | 5.34 | 5.47 | 5.46 | 4.48 | 3.89 | 4.19 | 3.42 | 3.90 | 3.73 | 3.89 | |||||||
Benchmarks | ||||||||||||||||||||||||||||
P/BV Ratio, Competitors5 | ||||||||||||||||||||||||||||
Procter & Gamble Co. | 7.78 | 7.87 | 7.46 | 7.47 | 7.41 | 7.83 | 8.15 | 7.56 | 6.97 | 7.42 | 8.63 | 8.70 | 7.38 | 7.40 | 7.24 | 6.74 | 7.33 | 7.09 | 6.56 | 6.78 | 6.54 |
Based on: 10-Q (reporting date: 2024-06-30), 10-K (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-K (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30).
1 Data adjusted for splits and stock dividends.
2 Q1 2025 Calculation
BVPS = Stockholders’ equity ÷ No. shares of common stock outstanding
= 703,590,000 ÷ 56,388,228 = 12.48
3 Closing price as at the filing date of e.l.f. Beauty, Inc. Quarterly or Annual Report.
4 Q1 2025 Calculation
P/BV ratio = Share price ÷ BVPS
= 160.83 ÷ 12.48 = 12.89
5 Click competitor name to see calculations.
The share price of the company exhibits a general upward trend over the observed periods from June 2019 through June 2024. Starting at $17.31, the price experiences moderate fluctuations initially, with a slight dip around the first quarter of 2020 reaching $16.57, likely influenced by broader market conditions during that period. From mid-2020 onwards, the share price demonstrates a strong positive momentum, increasing substantially to a peak of $184.77 in September 2023 before showing a minor decline to $160.83 by June 2024. This significant rise indicates growing investor confidence or improved company performance factors driving valuation gains.
Book value per share (BVPS) shows a steady, consistent increase throughout the timeline, moving from $4.45 in June 2019 to $12.48 in June 2024. This gradual growth reflects an ongoing strengthening of the company's net asset value on a per-share basis, suggesting healthy accumulation of equity or retained earnings, enhancing the intrinsic value of the shares over time.
The price-to-book value ratio (P/BV) exhibits more volatility in comparison to BVPS and share price. Initially, the ratio fluctuates between approximately 3.4 and 4.5, showing moderate market valuation relative to book value. From mid-2021 onward, the P/BV rises markedly, peaking at 16.09 in March 2024 before a slight downward adjustment to 12.89 in June 2024. This elevated P/BV signals that the market price of the company’s shares is trading far above its book value, which may reflect investor expectations of future growth, high profitability prospects, or intangible assets not fully captured by book value.
Overall, the data reveals a company experiencing sustained growth in intrinsic value, accompanied by strong market valuation expansion, particularly over the latter periods. The rising share price coupled with increasing BVPS shows robust operational or financial performance, while the elevated and variable P/BV ratio indicates fluctuating market sentiment and optimism concerning the company’s prospects moving forward.